Thus, the drug Genz-644282 can be efficiently and selectively delivered to TfR1-expressing glioma cells by the The-05 nanovector, that is able to maintain the drug itself soluble in aqueous solution and to cross the blood-to-brain barrier. Here, TFRC is linked to central nervous system cancer.